Aurora Spine Announces Publication of REFINE Study's 12-Month Results

Aurora Spine Corporation announced the publication of the 12-month results from the REFINE study in the International Journal of Spine Surgery on October 9, 2026. The study evaluated the company's ZIP MIS Interlaminar Fusion System in patients with symptomatic neurogenic claudication due to lumbar spinal stenosis and degenerative disc disease. It was a multicenter trial involving spine surgeons and interventional pain specialists.